Yangqiu Li Selected Research

Hematopoietic Stem Cell Transplantation

1/2019	Notch inhibition enhances graft-versus-leukemia while reducing graft-versus-host disease.
11/2016	Oligoclonal expansion of TCR Vδ T cells may be a potential immune biomarker for clinical outcome of acute myeloid leukemia.
7/2016	Persistent donor derived Vδ4 T cell clones may improve survival for recurrent T cell acute lymphoblastic leukemia after HSCT and DLI.
1/2015	Evaluation of TCR repertoire diversity in patients after hematopoietic stem cell transplantation.
1/2015	Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation.
3/2014	Distribution and clonality of the vα and vβ T-cell receptor repertoire of regulatory T cells in leukemia patients with and without graft versus host disease.
4/2011	Frequency analysis of TRBV subfamily sjTRECs to characterize T-cell reconstitution in acute leukemia patients after allogeneic hematopoietic stem cell transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yangqiu Li Research Topics

Disease

60	Neoplasms (Cancer) 01/2024 - 06/2000
38	Leukemia 01/2023 - 03/2000
25	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024 - 09/2000
21	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2022 - 09/2000
18	Hematologic Neoplasms (Hematological Malignancy) 07/2023 - 06/2000
18	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 04/2010
17	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2023 - 11/2010
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2023 - 01/2017
9	Acute Promyelocytic Leukemia 01/2021 - 04/2005
7	Lymphoma (Lymphomas) 12/2023 - 04/2010
7	Multiple Myeloma 03/2022 - 05/2011
6	Myeloid Leukemia (Leukemia, Myelocytic) 04/2018 - 03/2000
5	B-Cell Lymphoma (Lymphoma, B Cell) 09/2023 - 01/2014
5	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2019 - 03/2014
4	T-Cell Lymphoma (Lymphoma, T Cell) 07/2022 - 03/2015
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2014 - 05/2011
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2013 - 02/2010
3	Stomach Neoplasms (Stomach Cancer) 06/2022 - 01/2020
3	Pathologic Complete Response 01/2022 - 04/2009
3	Carcinoma (Carcinomatosis) 01/2020 - 11/2014
3	Carcinogenesis 08/2019 - 01/2015
3	Melanoma (Melanoma, Malignant) 12/2018 - 01/2016
3	Residual Neoplasm 06/2016 - 01/2013
2	Autoimmune Diseases (Autoimmune Disease) 11/2023 - 12/2016
2	Aplastic Anemia (Anemia, Hypoplastic) 11/2023 - 01/2019
2	Ataxia Telangiectasia (Louis Bar Syndrome) 09/2023 - 10/2013
2	Retinoblastoma (Glioblastoma, Retinal) 06/2022 - 08/2019
2	B-Cell Leukemia (Leukemia, B Cell) 01/2022 - 01/2021
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 10/2016 - 08/2009
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 06/2016 - 09/2000
2	Blast Crisis (Blast Phase) 01/2014 - 09/2013
1	Immunoglobulin Light-chain Amyloidosis 01/2024
1	Thalassemia 01/2024
1	Paraproteinemias (Monoclonal Gammopathy) 01/2024
1	Exanthema (Rash) 12/2023

Drug/Important Bio-Agent (IBA)

31	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2023 - 01/2002
17	AntigensIBA 09/2022 - 01/2002
14	Proteins (Proteins, Gene)FDA Link 07/2023 - 03/2000
11	Immunoglobulins (Immunoglobulin)IBA 01/2024 - 10/2018
11	Chimeric Antigen ReceptorsIBA 09/2022 - 01/2017
10	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2016
9	RNA (Ribonucleic Acid)IBA 01/2023 - 02/2015
8	Small Interfering RNA (siRNA)IBA 08/2019 - 11/2010
7	Imatinib Mesylate (Gleevec)FDA Link 09/2021 - 04/2010
6	CytokinesIBA 11/2023 - 06/2015
6	Messenger RNA (mRNA)IBA 04/2016 - 03/2000
5	Immune Checkpoint ProteinsIBA 01/2024 - 04/2020
5	Immune Checkpoint InhibitorsIBA 12/2023 - 01/2020
5	Tyrosine Kinase InhibitorsIBA 09/2021 - 09/2013
4	VaccinesIBA 01/2023 - 04/2010
4	LigandsIBA 09/2022 - 09/2013
3	MucinsIBA 01/2024 - 01/2021
3	Gefitinib (Iressa)FDA Link 05/2023 - 11/2022
3	Transcription Factors (Transcription Factor)IBA 12/2022 - 02/2015
3	CateninsIBA 11/2020 - 06/2017
3	Long Noncoding RNAIBA 08/2019 - 09/2014
3	Peptides (Polypeptides)IBA 01/2019 - 10/2005
3	Oncogene Proteins (Oncogene Protein)IBA 01/2018 - 12/2012
3	3' Untranslated Regions (3' UTR)IBA 12/2016 - 12/2012
3	SYBR Green IIBA 04/2012 - 11/2010
2	ErbB Receptors (EGF Receptor)IBA 05/2023 - 11/2022
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 04/2023 - 12/2019
2	Tyrosine (L-Tyrosine)FDA Link 01/2023 - 01/2022
2	Monoclonal AntibodiesIBA 01/2023 - 05/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 01/2019
2	Disulfiram (Antabuse)FDA Link 10/2022 - 07/2022
2	Programmed Cell Death 1 ReceptorIBA 07/2022 - 01/2020
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 06/2022 - 08/2019
2	Cyclin D1IBA 06/2022 - 08/2019
2	Chemokine ReceptorsIBA 01/2022 - 03/2017
2	ChemokinesIBA 01/2021 - 03/2017
2	MicroRNAs (MicroRNA)IBA 01/2021 - 10/2018
2	MesothelinIBA 01/2021 - 01/2020
2	AnthelminticsIBA 11/2020 - 04/2018
2	pyrvinium (Vankin)FDA Link 11/2020 - 04/2018
2	ChromatinIBA 01/2020 - 02/2015
2	InterferonsIBA 01/2019 - 04/2010
2	Interleukin-2 (IL2)IBA 01/2019 - 07/2015
2	bcr-abl Fusion ProteinsIBA 01/2018 - 10/2017
2	Insulin (Novolin)FDA Link 01/2017 - 01/2016
2	Inosine Triphosphate (ITP)IBA 10/2016 - 08/2009
2	NF-kappa B (NF-kB)IBA 11/2014 - 01/2014
2	A-Form DNA (A-DNA)IBA 01/2013 - 04/2010
2	gamma chain CD3 antigenIBA 05/2011 - 01/2011
1	venetoclaxIBA 01/2024
1	Thalidomide (Thalomid)FDA Link 01/2024
1	Amyloid (Amyloid Fibrils)IBA 01/2024
1	PlatinumIBA 12/2023
1	sintilimabIBA 12/2023
1	pembrolizumabIBA 12/2023

Therapy/Procedure

32	Immunotherapy 01/2024 - 06/2000
25	Therapeutics 12/2023 - 04/2010
13	Drug Therapy (Chemotherapy) 12/2023 - 10/2012
7	Hematopoietic Stem Cell Transplantation 01/2019 - 04/2011
3	Aftercare (After-Treatment) 03/2017 - 01/2013
2	Cell- and Tissue-Based Therapy (Cell Therapy) 03/2022 - 10/2015
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2017 - 06/2000
2	Ligation 01/2014 - 07/2013
2	Stem Cell Transplantation 07/2013 - 08/2005
2	Transplantation 04/2013 - 01/2009